MedTrace Logo

Evaluation of the Implementation of Expanded Carrier Screening Before Pregnancy in Hong Kong

NCT02742116 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-11-03

No results posted yet for this study

Summary

The objectives are to:

1. Assess patient's views and preferences in receiving expanded carrier screening
2. Perform qualitative study on post testing counselling on screen positive individuals and at risk couples

Conditions

  • Genetic Testing

Interventions

GENETIC

DNA screening before Pregnancy

Saliva/swab shall be collected from couple for Hereditary Disease DNA screening test. Blood sample shall be taken by venipuncture of women for Fragile X carrier screening A pre-test questionnaire will be conducted to assess subject's knowledge, views and preferences in receiving expanded carrier screening, choice of having concurrent or sequential screening, factors affecting their choices, anxiety level, and their willingness to pay for the test. A post-test self-administered questionnaire shall be filled in by the patient on receiving the test results. Couples who receive a screen positive result shall be subsequently referred to Queen Mary Hospital for joint counselling by clinical geneticist and gynaecologist. This consultation shall be audiotaped or videotaped.

Sponsors & Collaborators

  • The Family Planning Association of Hong Kong

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Grace CY Wong, MD · The Family Planning Association of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2016-10-31
Completion
2016-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02742116 on ClinicalTrials.gov